Proteins and protein pattern differences between glioma cell lines and glioblastoma multiforme

Clinical Cancer Research

Volumn 11, Issue 10, 2005, Pages 3624-3632

  Vogel, Timothy W ^a   Zhuang, Zhengping ^a   Li, Jie ^a   Okamoto, Hiroaki ^a   Furuta, Makoto ^a,b   Lee, Youn Soo ^a,c   Zeng, Weifen ^a,d,e   Oldfield, Edward H ^a   Vortmeyer, Alexander O ^a   Weil, Robert J ^a,e  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b SAGA UNIVERSITY   (Japan)

^c The Catholic University of Korea   (South Korea)

^d SUN YAT SEN UNIVERSITY   (China)

^e LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SEQUENCE; ANALYSIS OF VARIANCE; ARTICLE; CONTROLLED STUDY; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MICRODISSECTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

BRAIN NEOPLASMS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE EXPRESSION PROFILING; GLIOBLASTOMA; GLIOMA; PROTEOMICS; REPRODUCIBILITY OF RESULTS; SELECTION (GENETICS); TUMOR CELLS, CULTURED;

EID: 21044434153     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-04-2115     Document Type: Article

References (47)

1. Kleihues P, Cavenee WK, editors. Pathology and genetics of tumours of the central nervous system. In: World Health Organization classification of tumours. 2nd ed. Lyon: IARC; 2000.
2. Smith JS, Jenkins RB. Genetic alterations in adult diffuse glioma: occurrence, significance, and prognostic implications. Front Biosci 2000;5:213-31.
3. Russell DS, Bland JOW. A study of gliomas by the method of tissue culture. J Pathol 1933;36:273-83.
4. Ponten J, Macintyre EH. Long term culture of normal and neoplastic human glia. Acta Pathol Microbiol Scand 1968;74:465-86.
5. Giard DJ, Aaronson SA, Todaro GJ, et al. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst 1973;51:1417-23.
6. Dipasquale B, Colombatti M, Tridente G. Morphological heterogeneity and phenotype modifications during long term in vitro cultures of six new glioblastoma cell lines. Tumori 1990;76:2:172-8.
7. Zhuang Z, Bertheau P, Emmert-Buck MR. A microdissection technique for archival DNA analysis of specific cell populations in lesions 1 mm in size. Am J Pathol 1995;146:620-5.
8. Vortmeyer AO, Weil RJ, Zhuang Z. Proteomic applications for differential diagnosis of histologically-identical tumors. Neurology 2003;61:1626-7.
9. Palmer-Toy DE, Sarracino DA, Sgroi D, LeVangie R, Leopold DE. Direct acquisition of matrix-assisted laser desorption/ionization time-of-flight mass spectra from laser capture microdissected tissues. Clinical Chem 2000;46:1513-6.
10. Gottlieb M, Chavko M. Silver staining of native and denatured eukaryotic DNA in agarose gels. Anal Biochem 1987;165:33-7.
11. Blum H, Beier H, Gross HJ. Improved silver staining of plant-proteins, RNA, and DNA in polyacrylamide gels. Electrophoresis 1987;8:93-9.
12. Stone KL, Williams KR. Enzymatic digestion of proteins and HPLC peptide isolation. In: Matsudaira P, editor. A practical guide to protein and peptide purification for microsequencing. San Diego: Academic Press; 1993.
13. Perkins DN, Pappin DJC, Creasy DM, Cotrell JS. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 1999;20:3551-67.
14. Boeckmann B, Bairoch A, Apweiler R, et al. The SWISS-PROT protein knowledgebase and its supplement TrEMBL. Nucleic Acids Res 2003;31:365-70.
15. Moore RE, Young MK, Lee TD. Q score: an algorithm for evaluating SEQUEST database search results. J Am Soc Mass Spectrom 2002;13:378-86.
16. PubMed, Protein and OMIM databases: http://www.ncbi.nlm.nih.gov:80/ entrez. Accessed 2/7/2005.
17. Chen MH, Yang WK, Whang-Peng J, Lee LS, Huang TS. Differential inducibilities of GFAP expression, cytostasis and apoptosis in primary cultures of human astrocytic tumours. Apoptosis 1998;3:171-82.
18. Mapstone TB, Galloway PG. Expression of glial fibrillary acidic protein, vimentin, fibronectin, and N-myc oncoprotein in primary human brain tumor cell explants. Pediatr Neurosurg 1992;17:169-74.
19. Narayan RK, Heydorn WE, Creed GJ, Jacobowitz DM. Protein patterns in various malignant human brain tumors by two-dimensional gel electrophoresis. Cancer Res 1986;46:4685-94.
20. Hanash SM, Bobek MP, Rickman DS, et al. Integrating cancer genomics and proteomics in the post-genome era. Proteomics 2002;2:69-75.
21. Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH, Aebersold R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol 1999;17:994-9.
22. Hiratsuka M, Inoue T, Toda T, et al. Proteomics-based identification of differentially expressed genes in human gliomas: down-regulation of SIRT2 gene. Biochem Biophys Res Commun 2003;309:558-66.
23. Zhang R, Tremblay TL, McDermid A, Thibault P, Stanimirovic D. Identification of differentially expressed proteins in human glioblastoma cell lines and tumors. Glia 2003;42:194-208.
24. Pandita A, Aldape KD, Zadeh G, Guha A, James CD. Contrasting in vivo and in vitro fates of glioblastoma cell subpopulations with amplified EGFR. Genes Chromosomes Cancer 2004;39:29-33.
25. Pieper RO. Defined human cellular systems in the study of glioma development. Front Biosci 2003;8:s19-27.
26. Kruse CA, Molleston MC, Parks EP, Schiltz PM, Kleinschmidt-DeMasters BK, Hickey WF. A rat glioma model, CNS-1, with invasive characteristics similar to those of human gliomas: a comparison to 9 L gliosarcoma. J Neurooncol 1994;22:191-200.
27. Moorefield KS, Fry SJ, Horowitz JM. Sp2 DNA binding activity and trans-activation are negatively regulated in mammalian cells. J Biol Chem 2004;279:13911-24.
28. Henderson MJ, Russell AJ, Hird S, et al. EDD, the human hyperplastic discs protein, has a role in progesterone receptor coactivation and potential involvement in DNA damage response. J Biol Chem 2002;277:26468-78.
29. Breen EC, Tang K. Calcyclin (S100A6) regulates pulmonary fibroblast proliferation, morphology, and cytoskeletal organization in vitro. J Cell Biochem 2003;88:848-54.
30. Chang HY, Sneddon JB, Alizadeh AA, et al. Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds. PLoS Biol 2004;2:E7.
31. Chang HY, Chi JT, Dudoit S, et al. Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc Natl Acad Sci U S A 2002;99:12877-82.
32. Browning ET, Ruina M. Glial fibrillary acidic protein: norepinephrine stimulated phosphorylation in intact C-6 glioma cells. J Neurochem 1984;42:718-26.
33. Kang DE, Pietrzik CU, Baum L, et al. Modulation of amyloid β-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway. J Clin Invest 2000;106:1159-66.
34. Ramaswamy S, Golub TR. DNA microarrays in clinical oncology. J Clin Oncol 2002;20:1932-41.
35. Shai R, Shi T, Kremen TJ, et al. Gene expression profiling identifies molecular subtypes of gliomas. Oncogene 2003;31:4918-23.
36. Fuller GN, Hess KR, Rhee CH, et al. Molecular classification of human diffuse gliomas by multidimensional scaling analysis of gene expression profiles parallels morphology-based classification, correlates with survival, and reveals clinically-relevant novel glioma subsets. Brain Pathol 2002;12:108-16.
37. Sallinen SL, Sallinen PK, Haapasalo HK, et al. Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques. Cancer Res 2000;60:6617-22.
38. Mischel PS, Shai R, Shi T, et al. Identification of molecular subtypes of glioblastoma by gene expression profiling. Oncogene 2003;22:2361-73.
39. Godard S, Getz G, Delorenzi M, et al. Classification of human astrocytic gliomas on the basis of gene expression: a correlated group of genes with angiogenic activity emerges as a strong predictor of subtypes. Cancer Res 2003;63:6613-25.
40. van den Boom J, Wolter M, Kuick R, et al. Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction. Am J Pathol 2003;163:1033-43.
41. Khatua S, Peterson KM, Brown KM, et al. Overexpression of the EGFR/FKBP12/HIF-2α pathway identified in childhood astrocytomas by angiogenesis gene profiling. Cancer Res 2003;63:1865-70.
42. Nutt CL, Mani DR, Betensky RA, et al. Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. Cancer Res 2003;63:1602-7.
43. Fuller GN, Hess KR, Rhee CH, et al. Molecular classification of human diffuse gliomas by multidimensional scaling analysis of gene expression profiles parallels morphology-based classification, correlates with survival, and reveals clinically-relevant novel glioma subsets. Brain Pathol 2002;12:108-16.
44. Kim S, Dougherty ER, Shmulevich L, et al. Identification of combination gene sets for glioma classification. Mol Cancer Ther 2002;1:1229-36.
45. Rickman DS, Bobek MP, Misek DE, et al. Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis. Cancer Res 2001;61:6885-91.
46. Lal A, Lash AE, Altschul SF, et al. A public database for gene expression in human cancers. Cancer Res 1999;59:5403-7.
47. Zhuang Z, Lee YS, Zeng W, et al. Molecular genetic and proteomic analysis of synchronous malignant gliomas. Neurology 2004;62:2316-9.